ArticleInternational journal of molecular sciences2021

New Synthetic Lethality Re-Sensitizing Platinum-Refractory Cancer Cells to Cisplatin In Vitro: The Rationale to Co-Use PARP and ATM Inhibitors.

Watson P Folk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.